Elisabeth E Adderson
Physician in Memphis, TN
License number
Utah 187487-8905
Issued Date
Jun 27, 1992
Expiration Date
Jan 31, 2008
Category
Physician
Type
Physician/Surgeon CS (Schedule 2-5)
Address
Address
Memphis, TN
Organization information
See more information about Elisabeth E Adderson at bizstanding.comSt Jude Children's Research - Elisabeth E Adderson MD
262 Danny Thomas Pl, Memphis, TN 38105
Categories:
Electronic Commerce, Infectious Disease Physicians & Surgeons
Phone:
(901) 495-3300 (Phone)
Professional information
Dr. Elisabeth E Adderson, Memphis TN - MD (Doctor of Medicine)
Specialties:
Pediatric Infectious Disease Medicine
Address:
262 Danny Thomas Pl, Memphis 38105
(866) 226-4343 (Phone)
11980 San Vicente Blvd STE 101, Los Angeles 90049
(310) 208-7777 (Phone), (310) 445-8709 (Fax)
UCLA MEDICAL GROUP
11980 San Vicente Blvd STE 102, Los Angeles 90049
(310) 208-7777 (Phone), (310) 445-8709 (Fax)
(866) 226-4343 (Phone)
11980 San Vicente Blvd STE 101, Los Angeles 90049
(310) 208-7777 (Phone), (310) 445-8709 (Fax)
UCLA MEDICAL GROUP
11980 San Vicente Blvd STE 102, Los Angeles 90049
(310) 208-7777 (Phone), (310) 445-8709 (Fax)
Certifications:
Pediatric Infectious Disease Medicine, 2002, Pediatrics, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Alberta Faculty of Medicine And Dentistry
Misericordia Hosp
Dalhousie University
Wash U Sch Med
University of Alberta Faculty of Medicine And Dentistry
Misericordia Hosp
Dalhousie University
Wash U Sch Med
Elisabeth E Adderson, Memphis TN
Specialties:
Pediatric Infectious Disease Specialist
Address:
262 Danny Thomas Pl, Memphis, TN 38105
332 N Lauderdale St, Memphis, TN 38105
332 N Lauderdale St, Memphis, TN 38105
Education:
University of Alberta, Faculty of Medicine and Dentistry - Doctor of Medicine*
Board certifications:
American Board of Pediatrics Certification in Pediatrics*, American Board of Pediatrics Sub-certificate in Pediatric Infectious Diseases (Pediatrics)*
Elisabeth Adderson, Memphis TN
Work:
Sjcrh
262 Danny Thomas Pl, Memphis, TN 38105 Saint Jude Children's Research Hospital
332 N Lauderdale St, Memphis, TN 38105
262 Danny Thomas Pl, Memphis, TN 38105 Saint Jude Children's Research Hospital
332 N Lauderdale St, Memphis, TN 38105
Associate Member At St. Jude Children's Research Hospital
Position:
Associate Member at St. Jude Children's Research Hospital
Location:
Greater Memphis Area
Industry:
Research
Work:
St. Jude Children's Research Hospital
-
Associate Member
Group B Streptococcus Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
US Patent:
7645577, Jan 12, 2010
Filed:
Jul 26, 2006
Appl. No.:
11/493705
Inventors:
Elisabeth Adderson - Memphis TN, US
John Bohnsack - Salt Lake City UT, US
John Bohnsack - Salt Lake City UT, US
Assignee:
St. Jude Children's Research Hospital - Memphis TN
University of Utah Research Foundation - Salt Lake City UT
University of Utah Research Foundation - Salt Lake City UT
International Classification:
C12Q 1/68
US Classification:
435 6, 536 237, 536 2432, 4353201, 4352523
Abstract:
This invention provides isolated nucleic acids encoding polypeptides comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides. The invention provides nucleic acids encoding Group B streptococcal Ema polypeptides EmaA, EmaB, EmaC, EmaD and EmaE. The present invention provides isolated polypeptides comprising amino acid sequences of Group B streptococcal polypeptides EmaA, EmaB, EmaC, EmaD and EmaE, including analogs, variants, mutants, derivatives and fragments thereof. Ema homologous polypeptides from additional bacterial species, including and are also provided. Antibodies to the Ema polypeptides and immunogenic fragments thereof are also provided. The present invention relates to the identification and prevention of infections by virulent forms of streptococci. This invention provides pharmaceutical compositions, immunogenic compositions, vaccines, and diagnostic and therapeutic methods of use of the isolated polypeptides, antibodies thereto, and nucleic acids. Assays for compounds which modulate the polypeptides of the present invention for use in therapy are also provided.
Group B Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
US Patent:
7892552, Feb 22, 2011
Filed:
Dec 7, 2009
Appl. No.:
12/632269
Inventors:
Elisabeth Adderson - Memphis TN, US
John Bohnsack - Salt Lake City UT, US
John Bohnsack - Salt Lake City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
St. Jude Children's Research Hospital - Memphis TN
St. Jude Children's Research Hospital - Memphis TN
International Classification:
A61K 39/40
US Classification:
4241651, 4242441, 5303871, 435 71, 435 732
Abstract:
This invention provides isolated nucleic acids encoding polypeptides comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides. The invention provides nucleic acids encoding Group B streptococcal Ema polypeptides EmaA, EmaB, EmaC, EmaD and EmaE. The present invention provides isolated polypeptides comprising amino acid sequences of Group B streptococcal polypeptides EmaA, EmaB, EmaC, EmaD and EmaE, including analogs, variants, mutants, derivatives and fragments thereof. Ema homologous polypeptides from additional bacterial species, including and are also provided. Antibodies to the Ema polypeptides and immunogenic fragments thereof are also provided. The present invention relates to the identification and prevention of infections by virulent forms of streptococci. This invention provides pharmaceutical compositions, immunogenic compositions, vaccines, and diagnostic and therapeutic methods of use of the isolated polypeptides, antibodies thereto, and nucleic acids. Assays for compounds which modulate the polypeptides of the present invention for use in therapy are also provided.
Group B Streptococcus Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
US Patent:
2004007, Apr 15, 2004
Filed:
Jul 8, 2003
Appl. No.:
10/333002
Inventors:
Elisabeth Adderson - Memphis TN, US
John Bohnsack - Salt Lake City UT, US
John Bohnsack - Salt Lake City UT, US
International Classification:
A61K039/02, C07H021/04, C07K014/315, C12N001/21
US Classification:
424/190100, 530/350000, 435/069100, 435/320100, 435/252300, 536/023700
Abstract:
This invention provides isolated nucleic acids encoding polypeptides comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides. The invention provides nucleic acids encoding Group B streptococcal Ema polypeptides EmaA, EmaB, EmaC, EmaD and EmaE. The present invention provides isolated polypeptides comprising amino acid sequences of Group B streptococcal polypeptides EmaA, EmaB, EmaC, EmaD and EmaE, including analogs, variants, mutants, derivatives and fragments thereof. Ema homologous polypeptides from additional bacterial species, including and are also provided. Antibodies to the Ema polypeptides and immunogenic fragments thereof are also provided. The present invention relates to the identification and prevention of infections by virulent forms of streptococci. This invention provides pharmaceutical compositions, immunogenic compositions, vaccines, and diagnostic and therapeutic methods of use of the isolated polypeptides, antibodies thereto, and nucleic acids. Assays for compounds which modulate the polypeptides of the present invention for use in therapy are also provided.
Group B Streptococcus Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
US Patent:
2013012, May 23, 2013
Filed:
Feb 18, 2011
Appl. No.:
13/030660
Inventors:
Elisabeth Adderson - Memphis TN, US
John Bohnsack - Salt Lake City UT, US
John Bohnsack - Salt Lake City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
St. Jude Children's Research Hospital - Memphis TN
St. Jude Children's Research Hospital - Memphis TN
International Classification:
C07K 14/315, C07K 16/40, A61K 39/09, C07K 16/12, C12Q 1/68, G01N 33/68
US Classification:
4241391, 435 611, 435 734, 435188, 435325, 435331, 435348, 435362, 435365, 435366, 435419, 4352523, 43525231, 43525233, 43525234, 43525235, 4352542, 4353201, 536 237, 530350, 4241901, 5303879, 5303913
Abstract:
This invention provides an isolated nucleic acid encoding a polypeptide comprising amino acid sequences of a streptococcal matrix adhesion E (EmaE) polypeptide. Antibodies to the EmaE polypeptide and immunogenic fragments thereof are also provided. This invention provides pharmaceutical compositions, immunogenic compositions, vaccines, and diagnostic and therapeutic methods of use of the isolated polypeptide, antibodies thereto, and nucleic acids.
Methods And Compositions For Diagnosing And Preventing A Group B Streptococcal Infection
US Patent:
7588773, Sep 15, 2009
Filed:
Aug 19, 2005
Appl. No.:
11/574067
Inventors:
Linda Jeannine Brady - Gainesville FL, US
Kyle N. Seifert - Harrisonburg VA, US
Elisabeth E. Adderson - Memphis TN, US
John F. Bohnsack - Salt Lake City UT, US
Kyle N. Seifert - Harrisonburg VA, US
Elisabeth E. Adderson - Memphis TN, US
John F. Bohnsack - Salt Lake City UT, US
Assignee:
St. Jude Children's Research Hospital - Memphis TN
University of Florida - Gainesville FL
University of Utah Research Foundation - Salt Lake City UT
University of Florida - Gainesville FL
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 39/09, C07K 14/315, C07H 21/04, C12P 21/04, C12N 15/00
US Classification:
4242441, 4241841, 530350, 435 697, 4353201, 536 237
Abstract:
The present invention provides a group B (GBS) surface antigen, designated epsilon antigen, that is co-expressed with the delta antigen on a subset of serotype III GBS. Epsilon is expressed on more pathogenic Restriction Digest Pattern (RDP) III-3 GBS, but not on RDP types 1, 2, or 4. Accordingly, the present invention provides compositions and methods for detecting a group B serotype III, RDP III-3 strain. Vaccines and methods of identifying agents which inhibit adhesion of a group B cell to a host cell are also provided.